• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索差异:印度2型糖尿病门诊患者中初治患者、常规使用者和惰性患者的比较分析

Exploring disparities: A comparative analysis of insulin-naïve, regular users, and inertia patients among type 2 diabetes mellitus outpatients in India.

作者信息

Atal Shubham, Bohra Arwa, Kalra Shamsher S, Balakrishnan S, Joshi Rajnish

机构信息

Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Bhopal, Madhya Pradesh, India.

Department of General Medicine, All India Institute of Medical Sciences Bhopal, Bhopal, Madhya Pradesh, India.

出版信息

J Family Med Prim Care. 2024 Oct;13(10):4244-4251. doi: 10.4103/jfmpc.jfmpc_87_24. Epub 2024 Oct 18.

DOI:10.4103/jfmpc.jfmpc_87_24
PMID:39629445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11610898/
Abstract

INTRODUCTION

Insulin utilization pattern varies greatly in type 2 diabetes mellitus (T2DM) patients. Clinical inertia in treatment intensification hinders glycemic control in T2DM management. This study investigated insulin prescription trends and various predictors among insulin naive, user, and insulin inertia (II) patients in T2DM.

METHODOLOGY

A retrospective analysis of T2DM patient records from the diabetes clinic at a tertiary care center was conducted. Data on socio-demographics, anthropometry, disease characteristics, comorbidities, adherence, and medication prescribing patterns were collected. Analysis was done using tests of significance, odds ratio (OR), and multivariate logistic regression.

RESULTS

A total of 950 records were analyzed, with 17.3% of patients identified as insulin users (IU), 70.9% being insulin-naïve (IN), and 11.8% having II. IUs had significantly higher glycemic levels including HbA1c, fasting, postprandial, and random blood sugars compared to the other groups. Higher HbA1c levels were associated with significantly increased odds of insulin usage (OR: 3.46, confidence interval (CI): 1.94-6.16), while individuals taking sulfonylureas had lower odds of insulin usage (OR: 0.27, CI: 0.08-0.91). A significant association was also seen with the total number of oral antidiabetic drugs prescribed (four drugs; OR: 15.6, and five drugs; OR: 9.1). Other factors did not show a significant association. The regression model showed HbA1c level as low as 7.9% could indicate a future insulin requirement in 22% of patients.

CONCLUSION

The study outlines differences in characteristics and parameters among T2DM patients who require or do not require insulin and highlights the challenges in insulin initiation in Indian T2DM patients. Findings on II underscore the need for timely treatment intensification.

摘要

引言

2型糖尿病(T2DM)患者的胰岛素使用模式差异很大。治疗强化方面的临床惰性阻碍了T2DM管理中的血糖控制。本研究调查了T2DM中初治胰岛素患者、胰岛素使用者和胰岛素惰性(II)患者的胰岛素处方趋势及各种预测因素。

方法

对一家三级护理中心糖尿病门诊的T2DM患者记录进行回顾性分析。收集了社会人口统计学、人体测量学、疾病特征、合并症、依从性和药物处方模式等数据。使用显著性检验、比值比(OR)和多变量逻辑回归进行分析。

结果

共分析了950份记录,其中17.3%的患者被确定为胰岛素使用者(IU),70.9%为初治胰岛素患者(IN),11.8%有II。与其他组相比,IU的血糖水平显著更高,包括糖化血红蛋白(HbA1c)、空腹血糖、餐后血糖和随机血糖。较高的HbA1c水平与胰岛素使用几率显著增加相关(OR:3.46,置信区间(CI):1.94 - 6.16),而服用磺脲类药物的个体胰岛素使用几率较低(OR:0.27,CI:0.08 - 0.91)。还发现与开具的口服抗糖尿病药物总数存在显著关联(四种药物;OR:15.6,五种药物;OR:9.1)。其他因素未显示出显著关联。回归模型显示,低至7.9%的HbA1c水平可能表明22%的患者未来需要胰岛素治疗。

结论

该研究概述了需要或不需要胰岛素的T2DM患者在特征和参数方面的差异,并突出了印度T2DM患者开始使用胰岛素的挑战。关于II的研究结果强调了及时强化治疗的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d2/11610898/0ef4342b258b/JFMPC-13-4244-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d2/11610898/10bb9fb29b73/JFMPC-13-4244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d2/11610898/0ef4342b258b/JFMPC-13-4244-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d2/11610898/10bb9fb29b73/JFMPC-13-4244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d2/11610898/0ef4342b258b/JFMPC-13-4244-g002.jpg

相似文献

1
Exploring disparities: A comparative analysis of insulin-naïve, regular users, and inertia patients among type 2 diabetes mellitus outpatients in India.探索差异:印度2型糖尿病门诊患者中初治患者、常规使用者和惰性患者的比较分析
J Family Med Prim Care. 2024 Oct;13(10):4244-4251. doi: 10.4103/jfmpc.jfmpc_87_24. Epub 2024 Oct 18.
2
Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study.英国 1990-2017 年 2 型糖尿病成人起始和强化糖尿病治疗中的种族差异:一项队列研究。
PLoS Med. 2020 May 15;17(5):e1003106. doi: 10.1371/journal.pmed.1003106. eCollection 2020 May.
3
A Retrospective Analysis of Therapeutic Inertia in Type 2 Diabetes Management Across a Diverse Population of Health Care Organizations in the USA.美国不同医疗保健机构中2型糖尿病管理治疗惰性的回顾性分析
Diabetes Ther. 2021 Feb;12(2):581-594. doi: 10.1007/s13300-020-00993-w. Epub 2021 Jan 18.
4
Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.对于新诊断的糖化血红蛋白(HbA1c)>9%的 2 型糖尿病患者,短期强化胰岛素治疗可能是首选。
J Diabetes. 2017 Oct;9(10):890-893. doi: 10.1111/1753-0407.12581. Epub 2017 Aug 22.
5
Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes.2 型糖尿病患者基础胰岛素的缓慢滴定和延迟强化。
J Manag Care Spec Pharm. 2018 Apr;24(4):390-400. doi: 10.18553/jmcp.2017.17218. Epub 2017 Nov 16.
6
Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.基层医疗中 2 型糖尿病患者高血糖治疗的临床惰性。
Curr Med Res Opin. 2013 Nov;29(11):1495-502. doi: 10.1185/03007995.2013.833089. Epub 2013 Sep 6.
7
Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study.胰岛素甘精 300 单位/毫升个体化靶向治疗在韩国初诊 2 型糖尿病患者中的真实世界结局:TOBE 研究。
Adv Ther. 2024 May;41(5):1967-1982. doi: 10.1007/s12325-024-02830-z. Epub 2024 Mar 21.
8
Clinical Inertia in the Management of Type 2 Diabetes Mellitus: A Systematic Review.临床惰性在 2 型糖尿病管理中的作用:系统评价。
Medicina (Kaunas). 2023 Jan 16;59(1):182. doi: 10.3390/medicina59010182.
9
A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study.糖尿病中抗糖尿病和抗高血压药物过度治疗与去强化治疗的横断面研究:TEMD过度治疗研究
Diabetes Ther. 2020 May;11(5):1045-1059. doi: 10.1007/s13300-020-00779-0. Epub 2020 Feb 22.
10
Delays in Insulin Initiation among Patients with Type 2 Diabetes Mellitus in Southeast China: A Retrospective, Real-World Study.中国东南部2型糖尿病患者胰岛素起始治疗延迟情况:一项回顾性真实世界研究
Diabetes Metab Syndr Obes. 2020 Aug 25;13:3059-3068. doi: 10.2147/DMSO.S256381. eCollection 2020.

本文引用的文献

1
Clinical Inertia in the Management of Type 2 Diabetes Mellitus: A Systematic Review.临床惰性在 2 型糖尿病管理中的作用:系统评价。
Medicina (Kaunas). 2023 Jan 16;59(1):182. doi: 10.3390/medicina59010182.
2
Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver.印度年轻起病 2 型糖尿病患者亚组人群揭示胰岛素缺乏为主要驱动因素。
Diabetologia. 2022 Jan;65(1):65-78. doi: 10.1007/s00125-021-05543-y. Epub 2021 Oct 23.
3
Assessment of clinical inertia in people with diabetes within primary care.
基层医疗中糖尿病患者临床惰性的评估。
J Eval Clin Pract. 2021 Apr;27(2):365-370. doi: 10.1111/jep.13429. Epub 2020 Jun 16.
4
Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective Study.肥胖的2型糖尿病控制不佳患者的临床惰性:一项观察性回顾性研究
Diabetes Ther. 2020 Feb;11(2):437-451. doi: 10.1007/s13300-019-00745-5. Epub 2019 Dec 28.
5
Clinical inertia to insulin initiation and intensification in the UK: A focused literature review.英国胰岛素起始和强化治疗中的临床惰性:一项聚焦文献综述。
Prim Care Diabetes. 2017 Feb;11(1):3-12. doi: 10.1016/j.pcd.2016.09.003. Epub 2016 Oct 7.
6
Self-report measures of medication adherence behavior: recommendations on optimal use.药物依从性的自我报告测量方法:最佳使用建议。
Transl Behav Med. 2015 Dec;5(4):470-82. doi: 10.1007/s13142-015-0315-2. Epub 2015 Jul 9.
7
Delay in starting insulin after failure of other treatments in patients with type 2 diabetes mellitus.2型糖尿病患者在其他治疗失败后开始使用胰岛素的延迟情况。
Hippokratia. 2014 Oct-Dec;18(4):306-9.
8
Consensus evidence-based guidelines for insulin initiation, optimization and continuation in type 2 diabetes mellitus.2型糖尿病胰岛素起始、优化及继续治疗的基于证据的共识指南。
J Assoc Physicians India. 2014 Jul;62(7 Suppl):49-54.
9
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.2015年2型糖尿病高血糖管理:以患者为中心的方法:美国糖尿病协会和欧洲糖尿病研究协会立场声明更新版
Diabetes Care. 2015 Jan;38(1):140-9. doi: 10.2337/dc14-2441.
10
Results from the UK cohort of SOLVE: providing insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice.英国SOLVE队列研究结果:为常规临床实践中2型糖尿病控制不佳患者开始胰岛素治疗的时机提供见解。
Prim Care Diabetes. 2014 Apr;8(1):57-63. doi: 10.1016/j.pcd.2013.11.010. Epub 2013 Dec 27.